Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 139


Hepatitis C virus as a systemic disease: reaching beyond the liver.

Gill K, Ghazinian H, Manch R, Gish R.

Hepatol Int. 2016 May;10(3):415-23. doi: 10.1007/s12072-015-9684-3. Epub 2015 Dec 10. Review.


Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study.

Mrozikiewicz-Rakowska B, Maroszek P, Nehring P, Sobczyk-Kopciol A, Krzyzewska M, Kaszuba AM, Lukawska M, Chojnowska N, Kozka M, Bujalska-Zadrozny M, Ploski R, Krzymien J, Czupryniak L.

J Physiol Pharmacol. 2015 Oct;66(5):751-61.


Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.

Ruilope LM, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Ferreira AC, Pieper A, Kimmeskamp-Kirschbaum N, Bakris GL.

Am J Nephrol. 2014;40(6):572-81. doi: 10.1159/000371497. Epub 2015 Jan 10.


Clinical utility of serum beta-2-microglobulin as a predictor of diabetic complications in patients with type 2 diabetes without renal impairment.

Kim MK, Yun KJ, Chun HJ, Jang EH, Han KD, Park YM, Baek KH, Song KH, Cha BY, Park CS, Kwon HS.

Diabetes Metab. 2014 Dec;40(6):459-65. doi: 10.1016/j.diabet.2014.08.002. Epub 2014 Oct 7.


Early renal abnormalities as an indicator of cardiovascular risk in type 2 diabetes.

Viazzi F, Bonino B, Ratto E, De Cosmo S, Pontremoli R.

High Blood Press Cardiovasc Prev. 2014 Dec;21(4):257-60. doi: 10.1007/s40292-014-0067-y. Epub 2014 Aug 1. Review.


Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetes.

Jenks SJ, Conway BR, Hor TJ, Williamson RM, McLachlan S, Robertson C, Morling JR, Strachan MW, Price JF.

Diabet Med. 2014 Sep;31(9):1039-46. doi: 10.1111/dme.12456. Epub 2014 Apr 16.


Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study.

Al-Rubeaan K, Youssef AM, Subhani SN, Ahmad NA, Al-Sharqawi AH, Al-Mutlaq HM, David SK, AlNaqeb D.

PLoS One. 2014 Feb 21;9(2):e88956. doi: 10.1371/journal.pone.0088956. eCollection 2014.


Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus.

Boronat M, García-Cantón C, Quevedo V, Lorenzo DL, López-Ríos L, Batista F, Riaño M, Saavedra P, Checa MD.

Ren Fail. 2014 Mar;36(2):166-70. doi: 10.3109/0886022X.2013.835266. Epub 2013 Sep 24.


Intensive glycemic control in type 2 diabetics at high cardiovascular risk: do the benefits justify the risks?

Shurraw S, Tonelli M.

Kidney Int. 2013 Mar;83(3):346-8. doi: 10.1038/ki.2012.431.


Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.

Perkovic V, Heerspink HL, Chalmers J, Woodward M, Jun M, Li Q, MacMahon S, Cooper ME, Hamet P, Marre M, Mogensen CE, Poulter N, Mancia G, Cass A, Patel A, Zoungas S; ADVANCE Collaborative Group.

Kidney Int. 2013 Mar;83(3):517-23. doi: 10.1038/ki.2012.401. Epub 2013 Jan 9.


Epidemiology of diabetic kidney disease.

Reutens AT.

Med Clin North Am. 2013 Jan;97(1):1-18. doi: 10.1016/j.mcna.2012.10.001. Review.


Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: a systematic review for a KDOQI clinical practice guideline.

Slinin Y, Ishani A, Rector T, Fitzgerald P, MacDonald R, Tacklind J, Rutks I, Wilt TJ.

Am J Kidney Dis. 2012 Nov;60(5):747-69. doi: 10.1053/j.ajkd.2012.07.017. Epub 2012 Sep 19. Review.


[Relevance of diabetes in high cardiovascular risk hypertensive patients].

Segura J, de la Sierra A, Fernández S, Ruilope LM; en representación de los investigadores del estudio IDENTCARE.

Med Clin (Barc). 2013 Oct 5;141(7):287-91. doi: 10.1016/j.medcli.2012.05.032. Epub 2012 Jul 28. Spanish.


Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes.

Coca SG, Ismail-Beigi F, Haq N, Krumholz HM, Parikh CR.

Arch Intern Med. 2012 May 28;172(10):761-9. doi: 10.1001/archinternmed.2011.2230. Review. Erratum in: Arch Intern Med. 2012 Jul 23;172(14):1095.


The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients.

Halimi JM.

Diabetes Metab. 2012 Oct;38(4):291-7. doi: 10.1016/j.diabet.2012.04.001. Epub 2012 May 22. Review.


Diabetic nephropathy--the family physician's role.

Roett MA, Liegl S, Jabbarpour Y.

Am Fam Physician. 2012 May 1;85(9):883-9.


[Prevalence of chronic renal insufficiency in diabetic type 2 diabetes patients based on the estimated glomerular filtration rate and relation with cardiovascular risk].

Mur Martí T, Villaró Gabarrós M, Porta Martínez N, Jaén Manzanera A.

Med Clin (Barc). 2013 May 4;140(9):395-400. doi: 10.1016/j.medcli.2012.03.011. Epub 2012 May 8. Spanish.


Managing chronic kidney disease in type 2 diabetes in family practice.

Scott D, Davidson JA.

J Natl Med Assoc. 2011 Sep-Oct;103(9-10):952-9.


Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis.

Vejakama P, Thakkinstian A, Lertrattananon D, Ingsathit A, Ngarmukos C, Attia J.

Diabetologia. 2012 Mar;55(3):566-78. doi: 10.1007/s00125-011-2398-8. Epub 2011 Dec 22. Review.


Early renal function decline in type 2 diabetes.

Pavkov ME, Knowler WC, Lemley KV, Mason CC, Myers BD, Nelson RG.

Clin J Am Soc Nephrol. 2012 Jan;7(1):78-84. doi: 10.2215/CJN.07610711. Epub 2011 Nov 10.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk